NutraCea (PINK:NTRZ) Appoints a Leading Expert in Corporate Governance to the Board of Directors
In unison with a positioning of NutraCea (PINK:NTRZ) to grow operations with a new focus, the company made its next step to strengthen capacity.
Last Friday, NTRZ filed for SEC the appointment of its new member of the Board of Directors. The new member of the Board of Directors, Mr. Richard H. Koppes, was appointed to [...]
Neoprobe Corporation (OTC BB: NEOP) announces the employment agreement with Frederick O. Cope, Ph.D.
On 24.02.2010, in its 8k sec filing form, Item 5.02, related to change of directors, the Neoprobe Corporation (OTC BB: NEOP) announced an employment agreement with Frederick O. Cope, Ph.D., the Company’s Vice President, Pharmaceutical Research and Clinical Development. The new agreement came in to force on 15.02.2010 and will be terminated on 31.12.2010.
We couldn’t [...]
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Under this item 8k filing is done:
If a director has resigned or refuses to stand for re-election to the board of directors since the date of the last annual meeting of shareholders because of a disagreement with the company, known to an executive officer of the company on any matter relating to the operations, policies [...]